Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Receivables Turnover : 2.25 (As of Mar. 2024)

Hubei Biocause Heilen Pharmaceutical Co Receivables Turnover Chart

Hubei Biocause Heilen Pharmaceutical Co Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															2.71	2.56	1.62	1.92	2.25

Competitive Comparison of Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover falls into.

Hubei Biocause Heilen Pharmaceutical Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Biocause Heilen Pharmaceutical Co  (SZSE:301211) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Hubei Biocause Heilen Pharmaceutical Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Heilen Pharmaceutical Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description